189 related articles for article (PubMed ID: 25734253)
1. The effects of bariatric surgery on pancreatic lipid metabolism and blood flow.
Honka H; Koffert J; Hannukainen JC; Tuulari JJ; Karlsson HK; Immonen H; Oikonen V; Tolvanen T; Soinio M; Salminen P; Kudomi N; Mari A; Iozzo P; Nuutila P
J Clin Endocrinol Metab; 2015 May; 100(5):2015-23. PubMed ID: 25734253
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic metabolism, blood flow, and β-cell function in obese humans.
Honka H; Hannukainen JC; Tarkia M; Karlsson H; Saunavaara V; Salminen P; Soinio M; Mikkola K; Kudomi N; Oikonen V; Haaparanta-Solin M; Roivainen A; Parkkola R; Iozzo P; Nuutila P
J Clin Endocrinol Metab; 2014 Jun; 99(6):E981-90. PubMed ID: 24527718
[TBL] [Abstract][Full Text] [Related]
3. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
[TBL] [Abstract][Full Text] [Related]
4. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
[TBL] [Abstract][Full Text] [Related]
5. Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery.
Mäkinen J; Hannukainen JC; Karmi A; Immonen HM; Soinio M; Nelimarkka L; Savisto N; Helmiö M; Ovaska J; Salminen P; Iozzo P; Nuutila P
Diabetologia; 2015 May; 58(5):1055-62. PubMed ID: 25631620
[TBL] [Abstract][Full Text] [Related]
6. Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient?
Goday A; Benaiges D; Parri A; Ramón JM; Flores-Le Roux JA; Pedro Botet J;
Surg Obes Relat Dis; 2014; 10(5):871-6. PubMed ID: 25282193
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
[TBL] [Abstract][Full Text] [Related]
8. Morbid obesity and type 2 diabetes alter intestinal fatty acid uptake and blood flow.
Koffert J; Ståhle M; Karlsson H; Iozzo P; Salminen P; Roivainen A; Nuutila P
Diabetes Obes Metab; 2018 Jun; 20(6):1384-1390. PubMed ID: 29352513
[TBL] [Abstract][Full Text] [Related]
9. Brown adipose tissue lipid metabolism in morbid obesity: Effect of bariatric surgery-induced weight loss.
Dadson P; Hannukainen JC; Din MU; Lahesmaa M; Kalliokoski KK; Iozzo P; Pihlajamäki J; Karlsson HK; Parkkola R; Salminen P; Virtanen KA; Nuutila P
Diabetes Obes Metab; 2018 May; 20(5):1280-1288. PubMed ID: 29377423
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid uptake and blood flow in adipose tissue compartments of morbidly obese subjects with or without type 2 diabetes: effects of bariatric surgery.
Dadson P; Ferrannini E; Landini L; Hannukainen JC; Kalliokoski KK; Vaittinen M; Honka H; Karlsson HK; Tuulari JJ; Soinio M; Salminen P; Parkkola R; Pihlajamäki J; Iozzo P; Nuutila P
Am J Physiol Endocrinol Metab; 2017 Aug; 313(2):E175-E182. PubMed ID: 28400411
[TBL] [Abstract][Full Text] [Related]
11. Bariatric surgery: effects on glucose homeostasis.
Rubino F
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):497-507. PubMed ID: 16778583
[TBL] [Abstract][Full Text] [Related]
12. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
13. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.
Woelnerhanssen B; Peterli R; Steinert RE; Peters T; Borbély Y; Beglinger C
Surg Obes Relat Dis; 2011; 7(5):561-8. PubMed ID: 21429816
[TBL] [Abstract][Full Text] [Related]
14. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
Mingrone G
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery.
Clemente-Postigo M; Roca-Rodriguez Mdel M; Camargo A; Ocaña-Wilhelmi L; Cardona F; Tinahones FJ
Surg Obes Relat Dis; 2015; 11(4):933-9. PubMed ID: 25737102
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp.
Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim EA; Geloneze B
J Clin Endocrinol Metab; 2010 Aug; 95(8):3871-5. PubMed ID: 20484482
[TBL] [Abstract][Full Text] [Related]
17. Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion.
Novaes FS; Vasques AC; Pareja JC; Knop FK; Tura A; Chaim ÉA; Geloneze B
J Clin Endocrinol Metab; 2015 May; 100(5):1984-8. PubMed ID: 25742514
[TBL] [Abstract][Full Text] [Related]
18. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
Gumbs AA; Modlin IM; Ballantyne GH
Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes.
Geloneze B; Tambascia MA; Pareja JC; Repetto EM; Magna LA; Pereira SG
Obes Surg; 2001 Dec; 11(6):693-8. PubMed ID: 11775566
[TBL] [Abstract][Full Text] [Related]
20. Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes.
Dadson P; Landini L; Helmiö M; Hannukainen JC; Immonen H; Honka MJ; Bucci M; Savisto N; Soinio M; Salminen P; Parkkola R; Pihlajamäki J; Iozzo P; Ferrannini E; Nuutila P
Diabetes Care; 2016 Feb; 39(2):292-9. PubMed ID: 26681717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
